Wellbutrin Xl
Product Images NDC 21695-138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Wellbutrin Xl (NDC 21695-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fdd1fa5e 9dbf 4951 A8e9 33d06e05bdba 01)

FDA Label Image

Wellbutrin Xl 150mg (Fdd1fa5e 9dbf 4951 A8e9 33d06e05bdba 02)

Wellbutrin Xl 150mg (Fdd1fa5e 9dbf 4951 A8e9 33d06e05bdba 02)
This is a description of a medication with the NDC code 21696-137-30. The medication is called Wellbutrn AL 150", containing 150 mg of Bupropion HCI. The manufacturer is Biovall Corporation located in Mississauga, Ontario. The product ID is RW013730 and it is an extended-release tablet. Additional information is not available.*
FDA Label Image

Wellbutrin Xl 300mg (Fdd1fa5e 9dbf 4951 A8e9 33d06e05bdba 03)

Wellbutrin Xl 300mg (Fdd1fa5e 9dbf 4951 A8e9 33d06e05bdba 03)
This text is not coherent and seems to be a mix of fragments from different sources. Hence, "Not-Available" is the response.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.